ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt PathwaysSheng-Li Lin, Qing‐Yuan Sun|PLoS ONE|2010Cited by 122